Cytochrome P450 omega-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status - PubMed (original) (raw)

. 2002 Jul 12;277(28):25290-6.

doi: 10.1074/jbc.M201466200. Epub 2002 May 7.

Affiliations

• PMID: 11997390
• DOI: 10.1074/jbc.M201466200

Free article

Cytochrome P450 omega-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status

Timothy J Sontag et al. J Biol Chem. 2002.

Free article

Abstract

Postabsorptive elimination of the various forms of vitamin E appears to play a key role in regulation of tissue tocopherol concentrations, but mechanisms of tocopherol metabolism have not been elucidated. Here we describe a pathway involving cytochrome P450-mediated omega-hydroxylation of the tocopherol phytyl side chain followed by stepwise removal of two- or three-carbon moieties, ultimately yielding the 3'-carboxychromanol metabolite that is excreted in urine. All key intermediates of gamma-tocopherol metabolism via this pathway were identified in hepatocyte cultures using gas chromatography-mass spectrometry. NADPH-dependent synthesis of the initial gamma- and alpha-tocopherol 13'-hydroxy and -carboxy metabolites was demonstrated in rat and human liver microsomes. Functional analysis of several recombinant human liver P450 enzymes revealed that tocopherol-omega-hydroxylase activity was associated only with CYP4F2, which also catalyzes omega-hydroxylation of leukotriene B(4) and arachidonic acid. Tocopherol-omega-hydroxylase exhibited similar binding affinities but markedly higher catalytic activities for gamma-tocopherol than alpha-tocopherol, suggesting a role for this pathway in the preferential physiological retention of alpha-tocopherol and elimination of gamma-tocopherol. Sesamin potently inhibited tocopherol-omega-hydroxylase activity exhibited by CYP4F2 and rat or human liver microsomes. Since dietary sesamin also results in elevated tocopherol levels in vivo, this pathway appears to represent a functionally significant means of regulating vitamin E status.

PubMed Disclaimer

Similar articles

• Discovery, characterization, and significance of the cytochrome P450 omega-hydroxylase pathway of vitamin E catabolism.
  Parker RS, Sontag TJ, Swanson JE, McCormick CC. Parker RS, et al. Ann N Y Acad Sci. 2004 Dec;1031:13-21. doi: 10.1196/annals.1331.002. Ann N Y Acad Sci. 2004. PMID: 15753130 Review.
• Common variants of cytochrome P450 4F2 exhibit altered vitamin E-{omega}-hydroxylase specific activity.
  Bardowell SA, Stec DE, Parker RS. Bardowell SA, et al. J Nutr. 2010 Nov;140(11):1901-6. doi: 10.3945/jn.110.128579. Epub 2010 Sep 22. J Nutr. 2010. PMID: 20861217 Free PMC article.
• Influence of major structural features of tocopherols and tocotrienols on their omega-oxidation by tocopherol-omega-hydroxylase.
  Sontag TJ, Parker RS. Sontag TJ, et al. J Lipid Res. 2007 May;48(5):1090-8. doi: 10.1194/jlr.M600514-JLR200. Epub 2007 Feb 6. J Lipid Res. 2007. PMID: 17284776
• Role of human CYP4F2 in hepatic catabolism of the proinflammatory agent leukotriene B4.
  Jin R, Koop DR, Raucy JL, Lasker JM. Jin R, et al. Arch Biochem Biophys. 1998 Nov 1;359(1):89-98. doi: 10.1006/abbi.1998.0880. Arch Biochem Biophys. 1998. PMID: 9799565
• Fatty acid hydroxylation in rat kidney cortex microsomes.
  Ellin A, Orrenius S. Ellin A, et al. Mol Cell Biochem. 1975 Aug 30;8(2):69-79. doi: 10.1007/BF02116235. Mol Cell Biochem. 1975. PMID: 241011 Review.

Cited by

• δ- and γ-tocopherols, but not α-tocopherol, inhibit colon carcinogenesis in azoxymethane-treated F344 rats.
  Guan F, Li G, Liu AB, Lee MJ, Yang Z, Chen YK, Lin Y, Shih W, Yang CS. Guan F, et al. Cancer Prev Res (Phila). 2012 Apr;5(4):644-54. doi: 10.1158/1940-6207.CAPR-11-0521. Epub 2012 Feb 24. Cancer Prev Res (Phila). 2012. PMID: 22366914 Free PMC article.
• Urinary conjugated α-tocopheronolactone--a biomarker of oxidative stress in children with type 1 diabetes.
  Sharma G, Muller DP, O'Riordan SM, Bryan S, Dattani MT, Hindmarsh PC, Mills K. Sharma G, et al. Free Radic Biol Med. 2013 Feb;55:54-62. doi: 10.1016/j.freeradbiomed.2012.09.012. Epub 2012 Oct 27. Free Radic Biol Med. 2013. PMID: 23108104 Free PMC article.
• Synergistic Anticancer Effect of Tocotrienol Combined with Chemotherapeutic Agents or Dietary Components: A Review.
  Eitsuka T, Tatewaki N, Nishida H, Nakagawa K, Miyazawa T. Eitsuka T, et al. Int J Mol Sci. 2016 Sep 22;17(10):1605. doi: 10.3390/ijms17101605. Int J Mol Sci. 2016. PMID: 27669218 Free PMC article. Review.
• δ-Tocopherol reduces lipid accumulation in Niemann-Pick type C1 and Wolman cholesterol storage disorders.
  Xu M, Liu K, Swaroop M, Porter FD, Sidhu R, Firnkes S, Ory DS, Marugan JJ, Xiao J, Southall N, Pavan WJ, Davidson C, Walkley SU, Remaley AT, Baxa U, Sun W, McKew JC, Austin CP, Zheng W. Xu M, et al. J Biol Chem. 2012 Nov 16;287(47):39349-60. doi: 10.1074/jbc.M112.357707. Epub 2012 Oct 3. J Biol Chem. 2012. PMID: 23035117 Free PMC article.
• Distinctive Metabolism-Associated Gene Clusters That Are Also Prognostic in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma.
  Ding L, Ning S, Hu W, Xue Y, Yu S. Ding L, et al. Oxid Med Cell Longev. 2022 Sep 19;2022:6595989. doi: 10.1155/2022/6595989. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 36199423 Free PMC article. Retracted.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • GlyGen glycoinformatics resource
  • Guide to Pharmacology